Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  lobradimil
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-5 of 5 for your search:
Start Over
Phase II Randomized, Double-Blind Study of RMP-7 (A Bradykinin Analogue) plus CBDCA vs CBDCA/Placebo for Recurrent Malignant Glioma (Summary Last Modified 03/96)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ALK-01-017, DFCI-95066, NCI-V95-0789
Phase II Study of RMP-7 (a Bradykinin Analogue) plus CBDCA Administered Intra-Arterially for Recurrent Malignant Glioma (Summary Last Modified 08/96)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: YALE-HIC-8729, NCI-V96-0884
Lobradimil and Carboplatin in Treating Children With Brain Tumors
Phase: Phase II
Type: Treatment
Status: Completed
Age: 21 and under at diagnosis
Sponsor: NCI
Protocol IDs: CDR0000066169, NCI-98-C-0074H, CCG-09716, ALK-01-041, NCI-T98-0011, COG-C09716, T98-0011, NCT00019422
Phase I Study of RMP-7 (a Bradykinin Analogue) and Carboplatin for Refractory Childhood Brain Tumors
Phase: Phase I
Type: Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: ALK-01-036, NCI-96-C-0068C
Radiation Therapy Plus Carboplatin and Lobradimil in Treating Children With Newly Diagnosed Brain Stem Gliomas
Phase: Phase I
Type: Treatment
Status: Completed
Age: 3 to 21
Sponsor: NCI, Other
Protocol IDs: ADVL0012, COG-ADVL0012, CCG-ADVL0012, ALK-01-042, CCG-09802, CDR0000067715, ADVL00012, NCT00005602
Start Over